{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:48:45Z","timestamp":1760906925800},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1016\/j.eururo.2007.03.070","type":"journal-article","created":{"date-parts":[[2007,4,3]],"date-time":"2007-04-03T11:10:16Z","timestamp":1175598616000},"page":"525-530","source":"Crossref","is-referenced-by-count":13,"title":["Number of Daytime Micturitions and Volume Voided per Micturition in the Evaluation of Efficacy of Drugs for Overactive Bladder: Findings from Randomized Clinical Trials"],"prefix":"10.1016","volume":"52","author":[{"given":"Enrico","family":"Colli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Parazzini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenza","family":"Olivieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Cipriani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosanna","family":"Bertozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Meschia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Montorsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2007.03.070_bib1","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/nau.10052","article-title":"The standaridisation of terminology of lower urinary tract function: report from the standardisation subcommitee of the ICS","volume":"21","author":"Abrams","year":"2002","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.eururo.2007.03.070_bib2","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1097\/01.ju.0000103540.71683.e5","article-title":"Efficacy of antimuscarinic therapy for overactive bladder with varying degree of incontinence severity","volume":"171","author":"Landis","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2007.03.070_bib3","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/j.1464-410X.2004.04770.x","article-title":"Nocturia in patients with lower urinary tract symptoms: association with diurnal voiding patterns","volume":"93","author":"Ku","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2007.03.070_bib4","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1464-410X.2004.04606.x","article-title":"Randomized, double-blind placebo- and tolterodine-controlled trial of the once-daily antimuscarinic agent solifenacin in patients with symptomatic overactive bladder","volume":"93","author":"Chapple","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2007.03.070_bib5","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/BF02201987","article-title":"Efficacy and safety of two doses of tolterodine versus placebo in patients with detrusor overactivity and symptoms of frequency, urge incontinence, and urgency: urodynamic evaluation. The International Study Group","volume":"15","author":"Jonas","year":"1997","journal-title":"World J Urol"},{"key":"10.1016\/j.eururo.2007.03.070_bib6","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1046\/j.1464-410x.1998.00717.x","article-title":"Tolterodine, a new antimuscarinic agent: as effective but better tolerated than oxybutynin in patients with an overactive bladder","volume":"81","author":"Abrams","year":"1998","journal-title":"Br J Urol"},{"key":"10.1016\/j.eururo.2007.03.070_bib7","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/S0022-5347(05)68810-6","article-title":"Once daily controlled versus immediate release oxybutynin chloride for urge urinary incontinence. OROS Oxybutynin Study Group","volume":"161","author":"Anderson","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2007.03.070_bib8","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1001\/jama.280.23.1995","article-title":"Behavioral vs drug treatment for urge urinary incontinence in older women: a randomized controlled trial","volume":"280","author":"Burgio","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.eururo.2007.03.070_bib9","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1046\/j.1464-410x.1998.00501.x","article-title":"Efficacy and safety of tolterodine in patients with detrusor instability: a dose-ranging study","volume":"81","author":"Rentzhog","year":"1998","journal-title":"Br J Urol"},{"key":"10.1016\/j.eururo.2007.03.070_bib10","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s001929970003","article-title":"Clinical efficacy and safety of tolterodine compared to oxybutynin and placebo in patients with overactive bladder","volume":"10","author":"Drutz","year":"1999","journal-title":"I Urogynecol J"},{"key":"10.1016\/j.eururo.2007.03.070_bib11","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/S0022-5347(05)68951-3","article-title":"Clinical efficacy and safety of tolterodine compared to placebo in detrusor overactivity","volume":"161","author":"Millard","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2007.03.070_bib12","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2165\/00044011-200019020-00001","article-title":"Tolterodine, an effective and well tolerated treatment for urge incontinence and other overactive bladder symptoms","volume":"19","author":"Chancellor","year":"2000","journal-title":"Clin Drug Invest"},{"key":"10.1016\/j.eururo.2007.03.070_bib13","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0090-4295(00)01113-4","article-title":"Tolterodine once daily superior efficacy and tolerability in the treatment of the overactive bladder","volume":"57","author":"Van Kerrebroeck","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2007.03.070_bib14","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0301-2115(00)00561-3","article-title":"Tolterodine reduces the number of urge incontinence episodes in patients with an overactive bladder","volume":"98","author":"Jacquetin","year":"2001","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.eururo.2007.03.070_bib15","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/S0022-5347(05)66326-4","article-title":"Tolterodine: superior tolerability than and comparable efficacy to oxybutynin in individuals 50 yr old or older with overactive bladder: a randomized controlled trial","volume":"165","author":"Malone-Lee","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2007.03.070_bib16","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/S0149-2918(04)90174-9","article-title":"A randomized, double-blind, parallel-group comparison of controlled- and immediate-release oxybutynin chloride in urge urinary incontinence","volume":"26","author":"Barkin","year":"2004","journal-title":"Clin Ther"},{"key":"10.1016\/j.eururo.2007.03.070_bib17","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.eururo.2004.07.021","article-title":"Comparison of the efficacy of tolterodine and oxybutynin in different urodynamic severity grades of idiopathic detrusor overactivity","volume":"46","author":"Giannitsas","year":"2004","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2007.03.070_bib18","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1464-410X.2004.04561.x","article-title":"Solifenacil appears effective and well tolerated in patients with symptomatic idiopathic detrusor overactivity in a placebo controlled phase 2 dose finding study","volume":"93","author":"Chapple","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2007.03.070_bib19","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1097\/01.ju.0000140729.07840.16","article-title":"Randomized double blind placebo controlled trial of the once daily antimuscarinic agent solifenacin succinate in patients with overactive bladder","volume":"172","author":"Cardozo","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2007.03.070_bib20","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/nau.10162","article-title":"The association between overactive bladder symptoms and objective parameters from bladder diary and filling cystometry","volume":"23","author":"Van Brummen","year":"2004","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.eururo.2007.03.070_bib21","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.eururo.2005.05.015","article-title":"A comparison of the efficacy and tolerability of solifenacin succinate and extended release tolterodine at treating overactive bladder syndrome: results of the STAR trial","volume":"48","author":"Chapple","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2007.03.070_bib22","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.eururo.2005.02.024","article-title":"The effects of antimuscarinic treatments in overactive bladder: a systematic review and meta-analysis","volume":"48","author":"Chapple","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2007.03.070_bib23","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.eururo.2006.07.017","article-title":"Anticholinergic drugs in patients with bladder outlet obstruction and lower urinary tract symptoms: A systematic review","volume":"50","author":"Novara","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2007.03.070_bib24","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1046\/j.1464-410x.2000.00890.x","article-title":"Gender specificity of tolterodine on micturition and the diurnal variation of urine production of the conscious rat","volume":"86","author":"Yoshimura","year":"2000","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2007.03.070_bib25","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1111\/j.1464-4096.2004.04821.x","article-title":"The 24h frequency volume chart in adults reporting no voiding complaints defining reference values and analysing variables","volume":"93","author":"Van Haarst","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2007.03.070_bib26","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.eururo.2006.02.018","article-title":"A shifted paradigm for the further understanding, evaluation, and treatment of lower urinary tract symptoms in men: focus on the bladder","volume":"49","author":"Chapple","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2007.03.070_bib27","first-page":"110","article-title":"Lower sample size requirements for clinical trials studying diary symptoms in OAB patients: use of the overactive bladder symptom composite score for sample size determination in clinical trials","volume":"24","author":"Hamett","year":"2005","journal-title":"Neurourol Urodyn"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283807004526?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283807004526?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T11:54:21Z","timestamp":1546948461000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283807004526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["S0302283807004526"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2007.03.070","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2007,8]]}}}